Clinical variables | OR | 95%CI | p |
---|---|---|---|
Univariate analyses | |||
Age | 1.01 | 0.99–1.02 | 0.10 |
Male gender | 1.18 | 0.79–1.76 | 0.42 |
RF | 1.15 | 0.81–1.65 | 0.43 |
ACPA | 1.40 | 1.01–1.94 | 0.042 |
Disease duration | 1.00 | 0.98–1.02 | 0.99 |
Extra-articular features | 1.31 | 0.74–1.72 | 0.56 |
Radiographic damage | 0.85 | 0.61–1.16 | 0.30 |
Joint surgery | 1.32 | 0.83–2.08 | 0.23 |
Maintenance of remission | 0.65 | 0.47–0.91 | 0.014 |
CRP | 1.04 | 1.02–1.07 | 0.002 |
BMI | 1.02 | 0.89–1.08 | 0.52 |
HBP | 8.79 | 5.87–13.18 | < 0.0001 |
High cholesterol | 2.32 | 0.89–5.53 | 0.89 |
Smoking habit | 0.99 | 0.71–1.40 | 0.99 |
MetS | 3.99 | 2.83–5.64 | < 0.0001 |
T2D | 3.16 | 2.04–4.88 | < 0.0001 |
ASA | 2.59 | 0.98–4.13 | 0.08 |
CCS | 1.36 | 0.68–2.04 | 0.78 |
CCSs low dosage | 1.25 | 0.87–1.78 | 0.22 |
MTX | 1.67 | 0.98–2.75 | 0.08 |
HCQ | 0.62 | 0.42–1.01 | 0.09 |
LEF | 0.73 | 0.49–1.09 | 0.13 |
SSZ | 0.98 | 0.61–1.57 | 0.95 |
Biologic DMARDs | 0.58 | 0.42–1.01 | 0.07 |
TNFi | 0.99 | 0.71–1.37 | 0.95 |
Non-TNFi | 0.67 | 0.24–1.02 | 0.12 |
Multivariate analysis | |||
Age | 1.20 | 0.99–1.05 | 0.13 |
Male gender | 1.29 | 0.55–3.04 | 0.55 |
HBP | 2.03 | 1.04–4.14 | 0.042 |
T2D | 4.50 | 1.74–11.62 | 0.002 |
ACPA | 2.36 | 1.19–4.69 | 0.014 |
CRP | 1.07 | 1.03–1.14 | 0.040 |
Remission | 0.25 | 0.11–0.56 | 0.001 |